EMEA (Europe, Middle East and Africa) Over the Counter (OTC) Drugs & Dietary Supplements Market Report 2017

October 2017 | 118 pages | ID: EBE8694C50EWEN
QYResearch

Abstracts

In this report, the EMEA Over the Counter (OTC) Drugs & Dietary Supplements market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Over the Counter (OTC) Drugs & Dietary Supplements for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Over the Counter (OTC) Drugs & Dietary Supplements market competition by top manufacturers/players, with Over the Counter (OTC) Drugs & Dietary Supplements sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Pfizer
• Novartis International
• Roche Holding
• Merck
• Sanofi
• Johnson & Johnson
• Gilead Sciences
• GlaxoSmithKline
• Bayer Healthcare
• AstraZeneca
• Alacer
• Alcon
• Alfresa Pharma Corporation
• Alkalon
• Alliance Healthcare
• Allergan
• Reckitt Benckiser
• Bausch & Lomb

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Branded Drugs
• Generic Drugs

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Over the Counter (OTC) Drugs & Dietary Supplements for each application, including

• Pharmacies
• Grocery Stores
• Vitamin and Health Food Stores
• Online Pharmacy
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Over the Counter (OTC) Drugs & Dietary Supplements Market Report 2017

1 OVER THE COUNTER (OTC) DRUGS & DIETARY SUPPLEMENTS OVERVIEW

1.1 Product Overview and Scope of Over the Counter (OTC) Drugs & Dietary Supplements
1.2 Classification of Over the Counter (OTC) Drugs & Dietary Supplements
  1.2.1 EMEA Over the Counter (OTC) Drugs & Dietary Supplements Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Over the Counter (OTC) Drugs & Dietary Supplements Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Branded Drugs
  1.2.4 Generic Drugs
1.3 EMEA Over the Counter (OTC) Drugs & Dietary Supplements Market by Application/End Users
  1.3.1 EMEA Over the Counter (OTC) Drugs & Dietary Supplements Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Pharmacies
  1.3.3 Grocery Stores
  1.3.4 Vitamin and Health Food Stores
  1.3.5 Online Pharmacy
  1.3.6 Others
1.4 EMEA Over the Counter (OTC) Drugs & Dietary Supplements Market by Region
  1.4.1 EMEA Over the Counter (OTC) Drugs & Dietary Supplements Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Over the Counter (OTC) Drugs & Dietary Supplements (2012-2022)
  1.5.1 EMEA Over the Counter (OTC) Drugs & Dietary Supplements Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate (2012-2022)

2 EMEA OVER THE COUNTER (OTC) DRUGS & DIETARY SUPPLEMENTS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Over the Counter (OTC) Drugs & Dietary Supplements Market Competition by Players/Manufacturers
  2.1.1 EMEA Over the Counter (OTC) Drugs & Dietary Supplements Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Over the Counter (OTC) Drugs & Dietary Supplements Sale Price by Players (2012-2017)
2.2 EMEA Over the Counter (OTC) Drugs & Dietary Supplements (Volume and Value) by Type/Product Category
  2.2.1 EMEA Over the Counter (OTC) Drugs & Dietary Supplements Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Over the Counter (OTC) Drugs & Dietary Supplements Sale Price by Type (2012-2017)
2.3 EMEA Over the Counter (OTC) Drugs & Dietary Supplements (Volume) by Application
2.4 EMEA Over the Counter (OTC) Drugs & Dietary Supplements (Volume and Value) by Region
  2.4.1 EMEA Over the Counter (OTC) Drugs & Dietary Supplements Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Over the Counter (OTC) Drugs & Dietary Supplements Sales Price by Region (2012-2017)

3 EUROPE OVER THE COUNTER (OTC) DRUGS & DIETARY SUPPLEMENTS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales and Value (2012-2017)
  3.1.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate (2012-2017)
3.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales and Market Share by Type
3.3 Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales and Market Share by Application
3.4 Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales Volume by Countries (2012-2017)
  3.4.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Countries (2012-2017)
  3.4.3 Germany Over the Counter (OTC) Drugs & Dietary Supplements Sales and Growth Rate (2012-2017)
  3.4.4 France Over the Counter (OTC) Drugs & Dietary Supplements Sales and Growth Rate (2012-2017)
  3.4.5 UK Over the Counter (OTC) Drugs & Dietary Supplements Sales and Growth Rate (2012-2017)
  3.4.6 Russia Over the Counter (OTC) Drugs & Dietary Supplements Sales and Growth Rate (2012-2017)
  3.4.7 Italy Over the Counter (OTC) Drugs & Dietary Supplements Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Over the Counter (OTC) Drugs & Dietary Supplements Sales and Growth Rate (2012-2017)

4 MIDDLE EAST OVER THE COUNTER (OTC) DRUGS & DIETARY SUPPLEMENTS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Over the Counter (OTC) Drugs & Dietary Supplements Sales and Value (2012-2017)
  4.1.1 Middle East Over the Counter (OTC) Drugs & Dietary Supplements Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate (2012-2017)
4.2 Middle East Over the Counter (OTC) Drugs & Dietary Supplements Sales and Market Share by Type
4.3 Middle East Over the Counter (OTC) Drugs & Dietary Supplements Sales and Market Share by Application
4.4 Middle East Over the Counter (OTC) Drugs & Dietary Supplements Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Over the Counter (OTC) Drugs & Dietary Supplements Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Over the Counter (OTC) Drugs & Dietary Supplements Sales and Growth Rate (2012-2017)
  4.4.4 Israel Over the Counter (OTC) Drugs & Dietary Supplements Sales and Growth Rate (2012-2017)
  4.4.5 UAE Over the Counter (OTC) Drugs & Dietary Supplements Sales and Growth Rate (2012-2017)
  4.4.6 Iran Over the Counter (OTC) Drugs & Dietary Supplements Sales and Growth Rate (2012-2017)

5 AFRICA OVER THE COUNTER (OTC) DRUGS & DIETARY SUPPLEMENTS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales and Value (2012-2017)
  5.1.1 Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate (2012-2017)
5.2 Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales and Market Share by Type
5.3 Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales and Market Share by Application
5.4 Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales Volume by Countries (2012-2017)
  5.4.2 Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Countries (2012-2017)
  5.4.3 South Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Over the Counter (OTC) Drugs & Dietary Supplements Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Over the Counter (OTC) Drugs & Dietary Supplements Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Over the Counter (OTC) Drugs & Dietary Supplements Sales and Growth Rate (2012-2017)

6 EMEA OVER THE COUNTER (OTC) DRUGS & DIETARY SUPPLEMENTS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Over the Counter (OTC) Drugs & Dietary Supplements Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Novartis International
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Over the Counter (OTC) Drugs & Dietary Supplements Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Novartis International Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Roche Holding
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Over the Counter (OTC) Drugs & Dietary Supplements Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Roche Holding Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Merck
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Over the Counter (OTC) Drugs & Dietary Supplements Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Merck Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Sanofi
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Over the Counter (OTC) Drugs & Dietary Supplements Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Sanofi Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Johnson & Johnson
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Over the Counter (OTC) Drugs & Dietary Supplements Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Gilead Sciences
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Over the Counter (OTC) Drugs & Dietary Supplements Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 GlaxoSmithKline
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Over the Counter (OTC) Drugs & Dietary Supplements Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 GlaxoSmithKline Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Bayer Healthcare
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Over the Counter (OTC) Drugs & Dietary Supplements Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Bayer Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 AstraZeneca
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Over the Counter (OTC) Drugs & Dietary Supplements Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 AstraZeneca Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Alacer
6.12 Alcon
6.13 Alfresa Pharma Corporation
6.14 Alkalon
6.15 Alliance Healthcare
6.16 Allergan
6.17 Reckitt Benckiser
6.18 Bausch & Lomb

7 OVER THE COUNTER (OTC) DRUGS & DIETARY SUPPLEMENTS MANUFACTURING COST ANALYSIS

7.1 Over the Counter (OTC) Drugs & Dietary Supplements Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Over the Counter (OTC) Drugs & Dietary Supplements

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Over the Counter (OTC) Drugs & Dietary Supplements Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Over the Counter (OTC) Drugs & Dietary Supplements Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA OVER THE COUNTER (OTC) DRUGS & DIETARY SUPPLEMENTS MARKET FORECAST (2017-2022)

11.1 EMEA Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Over the Counter (OTC) Drugs & Dietary Supplements Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Over the Counter (OTC) Drugs & Dietary Supplements Price and Trend Forecast (2017-2022)
11.2 EMEA Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Type (2017-2022)
11.7 EMEA Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Over the Counter (OTC) Drugs & Dietary Supplements
Figure EMEA Over the Counter (OTC) Drugs & Dietary Supplements Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Over the Counter (OTC) Drugs & Dietary Supplements Sales Volume Market Share by Type (Product Category) in 2016
Figure Branded Drugs Product Picture
Figure Generic Drugs Product Picture
Figure EMEA Over the Counter (OTC) Drugs & Dietary Supplements Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Over the Counter (OTC) Drugs & Dietary Supplements by Application in 2016
Figure Pharmacies Examples
Table Key Downstream Customer in Pharmacies
Figure Grocery Stores Examples
Table Key Downstream Customer in Grocery Stores
Figure Vitamin and Health Food Stores Examples
Table Key Downstream Customer in Vitamin and Health Food Stores
Figure Online Pharmacy Examples
Table Key Downstream Customer in Online Pharmacy
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Over the Counter (OTC) Drugs & Dietary Supplements Market Size (Million USD) by Region (2012-2022)
Figure Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Over the Counter (OTC) Drugs & Dietary Supplements Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Over the Counter (OTC) Drugs & Dietary Supplements Revenue (Million USD) Status and Forecast by Countries
Figure Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Over the Counter (OTC) Drugs & Dietary Supplements Sales Volume and Growth Rate (2012-2022)
Figure EMEA Over the Counter (OTC) Drugs & Dietary Supplements Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Over the Counter (OTC) Drugs & Dietary Supplements Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Over the Counter (OTC) Drugs & Dietary Supplements Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Over the Counter (OTC) Drugs & Dietary Supplements Sales Share by Players (2012-2017)
Figure 2016 Over the Counter (OTC) Drugs & Dietary Supplements Sales Share by Players
Figure 2017 Over the Counter (OTC) Drugs & Dietary Supplements Sales Share by Players
Figure EMEA Over the Counter (OTC) Drugs & Dietary Supplements Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Over the Counter (OTC) Drugs & Dietary Supplements Revenue (Million USD) by Players (2012-2017)
Table EMEA Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Players (2012-2017)
Table 2016 EMEA Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Players
Table 2017 EMEA Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Players
Table EMEA Over the Counter (OTC) Drugs & Dietary Supplements Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Over the Counter (OTC) Drugs & Dietary Supplements Sales Share by Type (2012-2017)
Figure Sales Market Share of Over the Counter (OTC) Drugs & Dietary Supplements by Type (2012-2017)
Figure EMEA Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2012-2017)
Table EMEA Over the Counter (OTC) Drugs & Dietary Supplements Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Over the Counter (OTC) Drugs & Dietary Supplements by Type in 2016
Table EMEA Over the Counter (OTC) Drugs & Dietary Supplements Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Over the Counter (OTC) Drugs & Dietary Supplements Sales Share by Application (2012-2017)
Figure Sales Market Share of Over the Counter (OTC) Drugs & Dietary Supplements by Application (2012-2017)
Figure EMEA Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application in 2016
Table EMEA Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Over the Counter (OTC) Drugs & Dietary Supplements Sales Share by Region (2012-2017)
Figure Sales Market Share of Over the Counter (OTC) Drugs & Dietary Supplements by Region (2012-2017)
Figure EMEA Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share in 2016
Table EMEA Over the Counter (OTC) Drugs & Dietary Supplements Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Over the Counter (OTC) Drugs & Dietary Supplements by Region (2012-2017)
Figure EMEA Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share Regions in 2016
Table EMEA Over the Counter (OTC) Drugs & Dietary Supplements Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate (2012-2017)
Table Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units) by Type (2012-2017)
Table Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type (2012-2017)
Figure Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type in 2016
Table Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units) by Application (2012-2017)
Table Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application (2012-2017)
Figure Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application in 2016
Table Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units) by Countries (2012-2017)
Table Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Countries (2012-2017)
Figure Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Countries (2012-2017)
Figure Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Countries in 2016
Table Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue (Million USD) by Countries (2012-2017)
Table Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Countries (2012-2017)
Figure Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Countries (2012-2017)
Figure Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Countries in 2016
Figure Germany Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units) and Growth Rate (2012-2017)
Figure France Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units) and Growth Rate (2012-2017)
Figure UK Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Over the Counter (OTC) Drugs & Dietary Supplements Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units) by Type (2012-2017)
Table Middle East Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type (2012-2017)
Figure Middle East Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type (2012-2017)
Table Middle East Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units) by Applications (2012-2017)
Table Middle East Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Applications (2012-2017)
Figure Middle East Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application in 2016
Table Middle East Over the Counter (OTC) Drugs & Dietary Supplements Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Over the Counter (OTC) Drugs & Dietary Supplements Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Over the Counter (OTC) Drugs & Dietary Supplements Sales Volume Market Share by Countries in 2016
Table Middle East Over the Counter (OTC) Drugs & Dietary Supplements Revenue (Million USD) by Countries (2012-2017)
Table Middle East Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Countries (2012-2017)
Figure Middle East Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Countries (2012-2017)
Figure Middle East Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Countries in 2016
Figure Saudi Arabia Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units) by Type (2012-2017)
Table Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2012-2017)
Figure Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2012-2017)
Figure Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type in 2016
Table Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units) by Application (2012-2017)
Table Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2012-2017)
Figure Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2012-2017)
Table Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales Volume (K Units) by Countries (2012-2017)
Table Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Countries (2012-2017)
Figure Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Countries (2012-2017)
Figure Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Countries in 2016
Table Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue (Million USD) by Countries (2012-2017)
Table Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Countries (2012-2017)
Figure Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Countries (2012-2017)
Figure Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Countries in 2016
Figure South Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units) and Growth Rate (2012-2017)
Table Pfizer Over the Counter (OTC) Drugs & Dietary Supplements Basic Information List
Table Pfizer Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units) and Growth Rate (2012-2017)
Figure Pfizer Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share in EMEA (2012-2017)
Figure Pfizer Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share in EMEA (2012-2017)
Table Novartis International Over the Counter (OTC) Drugs & Dietary Supplements Basic Information List
Table Novartis International Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis International Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units) and Growth Rate (2012-2017)
Figure Novartis International Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share in EMEA (2012-2017)
Figure Novartis International Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share in EMEA (2012-2017)
Table Roche Holding Over the Counter (OTC) Drugs & Dietary Supplements Basic Information List
Table Roche Holding Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Holding Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units) and Growth Rate (2012-2017)
Figure Roche Holding Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share in EMEA (2012-2017)
Figure Roche Holding Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share in EMEA (2012-2017)
Table Merck Over the Counter (OTC) Drugs & Dietary Supplements Basic Information List
Table Merck Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units) and Growth Rate (2012-2017)
Figure Merck Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share in EMEA (2012-2017)
Figure Merck Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share in EMEA (2012-2017)
Table Sanofi Over the Counter (OTC) Drugs & Dietary Supplements Basic Information List
Table Sanofi Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units) and Growth Rate (2012-2017)
Figure Sanofi Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share in EMEA (2012-2017)
Figure Sanofi Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share in EMEA (2012-2017)
Table Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Basic Information List
Table Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units) and Growth Rate (2012-2017)
Figure Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share in EMEA (2012-2017)
Figure Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share in EMEA (2012-2017)
Table Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Basic Information List
Table Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units) and Growth Rate (2012-2017)
Figure Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share in EMEA (2012-2017)
Figure Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share in EMEA (2012-2017)
Table GlaxoSmithKline Over the Counter (OTC) Drugs & Dietary Supplements Basic Information List
Table GlaxoSmithKline Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units) and Growth Rate (2012-2017)
Figure GlaxoSmithKline Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share in EMEA (2012-2017)
Figure GlaxoSmithKline Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share in EMEA (2012-2017)
Table Bayer Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Basic Information List
Table Bayer Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units) and Growth Rate (2012-2017)
Figure Bayer Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share in EMEA (2012-2017)
Figure Bayer Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share in EMEA (2012-2017)
Table AstraZeneca Over the Counter (OTC) Drugs & Dietary Supplements Basic Information List
Table AstraZeneca Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units) and Growth Rate (2012-2017)
Figure AstraZeneca Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share in EMEA (2012-2017)
Figure AstraZeneca Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share in EMEA (2012-2017)
Table Alacer Over the Counter (OTC) Drugs & Dietary Supplements Basic Information List
Table Alcon Over the Counter (OTC) Drugs & Dietary Supplements Basic Information List
Table Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Basic Information List
Table Alkalon Over the Counter (OTC) Drugs & Dietary Supplements Basic Information List
Table Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Basic Information List
Table Allergan Over the Counter (OTC) Drugs & Dietary Supplements Basic Information List
Table Reckitt Benckiser Over the Counter (OTC) Drugs & Dietary Supplements Basic Information List
Table Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Over the Counter (OTC) Drugs & Dietary Supplements
Figure Manufacturing Process Analysis of Over the Counter (OTC) Drugs & Dietary Supplements
Figure Over the Counter (OTC) Drugs & Dietary Supplements Industrial Chain Analysis
Table Raw Materials Sources of Over the Counter (OTC) Drugs & Dietary Supplements Major Manufacturers in 2016
Table Major Buyers of Over the Counter (OTC) Drugs & Dietary Supplements
Table Distributors/Traders List
Figure EMEA Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Over the Counter (OTC) Drugs & Dietary Supplements Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share Forecast by Region (2017-2022)
Table EMEA Over the Counter (OTC) Drugs & Dietary Supplements Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share Forecast by Region (2017-2022)
Table Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share Forecast by Countries (2017-2022)
Table Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Over the Counter (OTC) Drugs & Dietary Supplements Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share Forecast by Countries (2017-2022)
Table Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share Forecast by Type (2017-2022)
Table EMEA Over the Counter (OTC) Drugs & Dietary Supplements Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources